CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 262,000 | ||
| 2025-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $399.28 | $399K | 3,130 |
| 2025-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,000 | $400.59 | $1.2M | 130 |
| 2025-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 266,000 | ||
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $135.42 | $2.0M | 14,625 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −295 | $396.95 | $117K | 14,330 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,380 | $398.02 | $549K | 12,950 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,415 | $399.07 | $565K | 11,535 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −2,910 | $400.09 | $1.2M | 8,625 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −5,103 | $400.79 | $2.0M | 3,522 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,470 | $402.06 | $591K | 2,052 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −2,052 | $403.00 | $827K | 0 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −105 | $396.87 | $42K | 7,770 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −820 | $397.96 | $326K | 6,950 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −920 | $399.20 | $367K | 6,030 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −2,289 | $400.24 | $916K | 3,741 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −2,068 | $400.86 | $829K | 1,673 |
| 2025-09-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −668 | $402.12 | $269K | 1,005 |
Page 201 of 214 · 4,273 trades